US Patent Issued to Artios Pharma on July 15 for "Heterocyclic compounds for use in the treatment of cancer" (British Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,886, issued on July 15, was assigned to Artios Pharma Ltd. (Cambridge, Great Britain).

"Heterocyclic compounds for use in the treatment of cancer" was invented by Peter Blencowe (Cambridge, Great Britain), Mark Charles (Cambridge, Great Britain), Tennyson Ekwuru (Cambridge, Great Britain), Harry Finch (Cambridge, Great Britain), Robert Heald (Cambridge, Great Britain), Hollie McCarron (Cambridge, Great Britain) and Martin Stockley (Cambridge, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The application relates to heterocyclic amide derivatives and their use in the treatment and prophylaxis of cancer, and to compositions containing sa...